Evidence map›Paper›PMID 41452433›Full record

ArticleJournal of robotic surgery2025

Selective by design: early adoption patterns of single-port off-clamp robotic partial nephrectomy in a high-volume center.

Umberto Anceschi, Salvatore Basile, Gabriele Tuderti, Aldo Brassetti, Riccardo Mastroianni, Eugenio Bologna, Leslie Claire Licari, Rocco Simone Flammia, Alfredo Maria Bove, Mariaconsiglia Ferriero and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Umberto AnceschiUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. umberto.anceschi@gmail.com.
Salvatore BasileUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Gabriele TudertiUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Aldo BrassettiUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Riccardo MastroianniUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Eugenio BolognaUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Leslie Claire LicariUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Rocco Simone FlammiaUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Alfredo Maria BoveUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Mariaconsiglia FerrieroUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Flavia ProiettiUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Salvatore GuaglianoneUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Costantino LeonardoUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.
Giuseppe SimoneUro-Oncology Program, Department of Urology, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntroduction of single-port (SP) technology into centers with a consolidated multi-port experience in robot-assisted partial nephrectomy (MP-RAPN) represents a conceptual shift rather than a natural transition. We analyzed the early institutional adoption of the SP platform, assessing its impact on case complexity, perioperative outcomes, and determinants of surgical selection within a purely off-clamp RAPN framework compared with the established MP standard. MATERIAL AND

methodsAll consecutive RAPN performed at our tertiary referral center between May 2024 and October 2025 were analyzed (n = 372). All procedures were performed using a standardized off-clamp technique, irrespective of tumor features. After SP platform introduction, cases were stratified as multi-port (MP, n = 294) or single-port (SP, n = 78). Baseline, anatomical, and perioperative variables were prospectively collected. Tumor complexity was graded using the RENAL score, and renal function was assessed through serial eGFR measurements. Continuous and categorical variables were analyzed with Mann-Whitney U and χ²/Fisher tests; SMD > 0.20 denoted clinical imbalance. Univariable and multivariable Firth logistic regression identified independent predictors of SP adoption.

resultsBaseline characteristics were similar (each p > 0.2), except for tumor size and RENAL score, which were lower in SP cases (2.8 vs. 4.1 cm; 6.4 vs. 7.8; each p < 0.001). Perioperative outcomes-including hemoglobin drop, transfusion rate, complications, and hospital stay-were equivalent (each p > 0.05). SP tumors showed higher Fuhrman 1 (20.5% vs. 4.9%, p = 0.008) and pT1a stage (78.8% vs. 52.9%, p = 0.003). A lower RENAL score (OR 0.64, p < 0.001) independently predicted SP selection (C-index = 0.77).

conclusionsIn a center routinely performing purely off-clamp RAPN, adoption of the single-port robotic platform proved technically feasible and oncologically safe, achieving perioperative and functional outcomes equivalent to the multi-port approach during its early institutional phase.

Indexed as

Kidney NeoplasmsNephrectomyRobotic Surgical ProceduresAgedFemaleHumansLength of StayMaleMiddle AgedRetrospective StudiesTreatment OutcomeMulti-portNephron-sparingOff-clampRenal cancerRobotic partial nephrectomySingle-port

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.